Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

This study has been withdrawn prior to enrollment.
(lack of patients who meet inclusion criteria; there was one screen failure)
Sponsor:
Collaborators:
Duke University
Eli Lilly and Company
Information provided by (Responsible Party):
Mark Feinglos, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01326117
First received: March 29, 2011
Last updated: July 25, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)